Michael L. Meyers, SVP, Chief Medical Officer at Syndax Pharmaceuticals Inc (SNDX), bought 500 shares at $15.46 ($8K) on 2021-04-26, disclosed to the SEC on 2021-04-28.
Open-market purchase of $8k SNDX by SVP, Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| SNDX | BUY | 2018-11-07 | $958 | — | Filing → |